Opposite effects of dopamine D2 and D3 receptors on learning and memory in the rat

European Journal of Pharmacology

Volumn 336, Issue 2-3, 1997, Pages 107-112

  Sigala, Sandra ^a   Missale, Cristina ^a   Spano, Pierfranco ^a  

^a Section of Pharmacology   (Italy)

Author keywords

Dopamine; Dopamine D2 receptor; Dopamine D3 receptor; Learning; Memory

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; APOMORPHINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; NAFADOTRIDE; QUINPIROLE; RECEPTOR SUBTYPE; SCOPOLAMINE; SULPIRIDE;

AMNESIA; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; MALE; MEMORY; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; RAT;

AMNESIA; ANIMALS; DOPAMINE AGENTS; LEARNING; MALE; MEMORY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; SCOPOLAMINE;

EID: 0030668212     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01235-1     Document Type: Article

References (35)

1. 2 receptor mechanisms contribute to age-related cognitive decline; The effects of quinpirole on memory and motor performance in monkeys. J. Neurosci. 15:1995;3429-3439.
2. 2 receptor mRNA. Brain Res. 564:1991;203-219.
3. Brito G.N.O., Davis B.J., Stoop L.C., Stanton M.E. Memory and septo-hippocampal cholinergic system in the rat. Psychopharmacology. 81:1983;315-320.
4. 3 dopamine receptors. Science. 260:1993;1814-1816.
5. Cumin R., Bandle E.F., Ganzu E., Haefely W.E. Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology. 78:1982;104-111.
6. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur. J. Neurosci. 6:1994;1384-1387.
7. Gingrich J.A., Caron M.G. Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16:1993;299-321.
8. Grecksch H., Matthies H. The role for dopaminergic mechanisms in the rat hippocampus in the consolidation of a brightness discrimination task. Psychopharmacology. 75:1981;165-168.
9. 2 receptor. Clin. Neuropharmacol. 18 (Suppl. 1):1995;S130-S142.
10. Hepler D.J., Olton D.S., Wenk G.L., Coyle J.T. Lesion in the nucleus basalis magnocellularis and medialseptal area of rats produce qualitatively similar memory impairments. J. Neurosci. 5:1985;866-873.
11. 1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience. 69:1995;1067-1074.
12. 1 dopamine antagonist. Eur. J. Pharmacol. 91:1983;153-154.
13. Ichihara K., Nabeshima T., Kameyama T. Effects of haloperidol, sulpiride and SCH 23390 on passive avoidance learning in mice. Eur. J. Pharmacol. 151:1988;435-442.
14. 2 receptors. Eur. J. Pharmacol. 213:1992;243-249.
15. 2 receptors facilitates in vivo acetylcholine release in the hippocampus. Brain Res. 618:1993;341-345.
16. 2 receptors. Neuroreport. 5:1994;674-676.
17. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature. 277:1979;93-96.
18. 3H ] hydroxy-N,N-di-n-propyl-2-aminotetralin Proc. Natl. Acad. Sci. USA. 89:1992;8155-8159.
19. Levin E.D., Rose J.E. Acute and chronic nicotinic interaction with dopamine systems and working memory performance. Ann. N.Y. Acad. Sci. 757:1995;245-252.
20. Lindvall O. Mesencephalic dopaminergic afferents to the lateral septal nucleus of the rat. Brain Res. 87:1975;89-95.
21. Lindvall, O., Bjorklund, A., 1983. Dopamine and norepinephrine-containing neuron systems: Their anatomy in the rat brain. In: Emson, P.C. (Ed.), Chemical Neuroanatomy. Raven Press, New York, NY. 229-234.
22. Nilsson O.G., Leanza G., Biorklund A. Acetylcholine release in the hippocampus: Regulation by monoaminergic afferents as measured by in vivo microdialysis. Brain Res. 584:1992;132-140.
23. Packard M.G., White N.M. Dissociation of hippocampus and caudate nucleus memory systems by post-training intracerebral injection of dopamine agonists. Behav. Neurosci. 105:1991;295-306.
24. 1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science. 251:1991;947-950.
25. 1 dopamine receptor in working memory: Local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J. Neurophysiol. 71:1994;515-528.
26. Schwegler H., Lipp H.P., Van der Loos H. Individual hippocampal mossy fibre distribution in mice correlates with two-way avoidance performance. Science. 214:1981;817-819.
27. Setler P.E., Sarau H.M., Zirkle C.L., Saunders L. The central effects of a novel dopamine agonist. Eur. J. Pharmacol. 50:1978;419-430.
28. Sokoloff P., Schwartz J.-C. Novel dopamine receptors half a decade later. Trends Pharmacol. Sci. 16:1995;270-275.
29. 3) as a target for neuroleptics. Nature. 347:1990;146-151.
30. Spano P.F., Govoni S., Trabucchi M. Studies on the pharmacological properties of dopamine receptors in various areas of the Central Nervous System. Adv. Biochem. Psychopharmacol. 29:1978;155-165.
31. 2 dopamine receptor. Nature. 29:1981;463-465.
32. 4 receptor gene with high affinity for the antipsychotic clozapine. Nature. 350:1991;610-614.
33. 2 receptor activation during the post-training period improves memory for visual or olfactory conditioned emotional responses in rats. Behav. Neural Biol. 55:1991;255-269.
34. White N.M., Packard M.G., Seamans J. Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: Possible autoreceptor effect. Behav. Neural Biol. 59:1993;230-241.
35. Woolverton W.L., Goldberg L.I., Ginos J.Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;678-683.